Trials of Novel Oral Anticoagulants for Stroke Prevention In Patients with Non-valvular Atrial Fibrillation

Publisher： Bentham Science Publishers

E-ISSN： 1875-6557|10|4|297-302

ISSN： 1573-403X

Source： Current Cardiology Reviews, Vol.10, Iss.4, 2014-11, pp. : 297-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 12, Iss. 1, 2014-04 ,pp. : 3-8

Bentham Science Publishers

Access to resources Recommend Favorite

Oral Anticoagulants vs. Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Verdict is in

By van Walraven C.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 4, 2003-12 ,pp. : 374-378

Springer Publishing Company

Access to resources Recommend Favorite

Stroke Prevention Using the Oral Direct Thrombin Inhibitor Ximelagatran in Patients with Non-Valvular Atrial Fibrillation

By  

Cerebrovascular Diseases, Vol. 21, Iss. 4, 2006-03 ,pp. : 279-293

Karger

Access to resources Recommend Favorite

Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation

By  

Cerebrovascular Diseases, Vol. 42, Iss. 3-4, 2016-04 ,pp. : 196-204

Karger

Access to resources Recommend Favorite

Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 2, 2016-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite